Eton PharmaceuticalsETON
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 45 institutions reported holding Eton Pharmaceuticals Inc. (ETON) in their 13F filings, up 1 from Q1 2024. 7 opened new positions and 6 sold out. The largest holders were Opaleye Management Inc. ($7.9M), Vanguard Group Inc. ($3.4M) and Nantahala Capital Management, LLC ($3.1M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Eton Pharmaceuticals Inc.
- CUSIP
- 29772L108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $4.5M |
| Exits | 6 | $239K |
All 13F filers, Q1 2024 → Q2 2024: 1,502,454 shares bought and 456,834 shares sold, net +1,045,620 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 45 holders
| Opaleye Management Inc. | 1.83% | Reduce -2.1% | 2,395,000 | $7.9M |
| Vanguard Group Inc. | 0.00% | No change | 1,027,688 | $3.4M |
| Nantahala Capital Management, LLC | 0.31% | New | 940,733 | $3.1M |
| Westside Investment Management, Inc. | 0.44% | Add +2.0% | 585,400 | $1.9M |
| Acuitas Investments, LLC | 1.02% | No change | 579,960 | $1.9M |
| National Philanthropic Trust | 0.03% | No change | 492,112 | $1.6M |
| Paradigm Capital Management Inc. | 0.04% | No change | 300,000 | $987K |
| BlackRock Inc. | 0.00% | Reduce -0.2% | 282,389 | $929K |
| Bridgeway Capital Management, LLC | 0.02% | No change | 253,362 | $834K |
| Parkman Healthcare Partners LLC | 0.11% | Add +27.1% | 253,197 | $833K |
| Geode Capital Management, LLC | 0.00% | Add +2.6% | 240,331 | $791K |
| Aristides Capital LLC | 0.27% | New | 200,000 | $658K |
| Susquehanna International Group, LLP | 0.00% | Reduce -32.6% | 134,288 | $442K |
| Thompson Siegel & Walmsley LLC | 0.01% | New | 127,724 | $420K |
| Acadian Asset Management LLC | 0.00% | Reduce -22.9% | 120,574 | $395K |
| Stonepine Capital Management, LLC | 0.33% | New | 110,000 | $362K |
| Renaissance Technologies | 0.00% | Add +63.8% | 106,500 | $350K |
| State Street Corp. | 0.00% | No change | 81,403 | $268K |
| Bank of New York Mellon Corp | 0.00% | No change | 74,491 | $245K |
| Northern Trust Corp. | 0.00% | Reduce -2.1% | 59,849 | $197K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -51.6% | 57,503 | $189K |
| Schonfeld Strategic Advisors LLC | 0.00% | Reduce -47.4% | 50,917 | $168K |
| Squarepoint Ops LLC | 0.00% | Reduce -16.0% | 41,255 | $136K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Reduce -11.3% | 34,847 | $115K |
| Blair William & Co. | 0.00% | Reduce -6.7% | 34,500 | $114K |
| Essex Investment Management Co. LLC | 0.02% | Reduce -65.3% | 27,252 | $90K |
| CHICAGO TRUST Co NA | 0.01% | No change | 16,700 | $55K |
| Two Sigma Investments, LP | 0.00% | Reduce -48.1% | 16,485 | $54K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 13,239 | $44K |
| XTX Topco Ltd | 0.00% | Reduce -16.8% | 11,739 | $39K |
| Quantum Private Wealth, LLC | 0.01% | No change | 11,500 | $38K |
| UBS Group AG | 0.00% | Add +462.1% | 11,018 | $36K |
| Dimensional Fund Advisors LP | 0.00% | No change | 10,564 | $35K |
| Raymond James & Associates | 0.00% | No change | 10,250 | $34K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -52.1% | 3,638 | $12K |
| ADAR1 Capital Management, LLC | 0.00% | New | 1,200 | $4K |
| Plante Moran Financial Advisors, LLC | 0.00% | No change | 1,000 | $3K |
| Royal Bank of Canada | 0.00% | Reduce -2.4% | 747 | $2K |
| BNP Paribas Financial Markets | 0.00% | No change | 350 | $1K |
| Osaic Holdings, Inc. | 0.00% | New | 300 | $987 |
| Morgan Stanley | 0.00% | Add +405.3% | 192 | $632 |
| Bank of America Corp. | 0.00% | New | 183 | $602 |
| Citadel Advisors | 0.00% | No change | 32 | $105 |
| Qube Research & Technologies Ltd | 0.00% | Reduce -100.0% | 4 | $14 |
| Lindbrook Capital, LLC | 0.00% | No change | 4 | $13 |
"% of holder's portfolio" is ETON's weight in each manager's 13F, not the share of Eton Pharmaceuticals Inc. the manager owns.